Literature DB >> 17610856

Glutaraldehyde cross-linked chitosan microspheres for controlled release of centchroman.

K C Gupta1, Fawzi Habeeb Jabrail.   

Abstract

Glutaraldehyde cross-linked chitosan microspheres were prepared for controlled release of centchroman, a nonsteroidal contraceptive. The cross-linked microspheres with low-molecular-weight (LMW) chitosan (260 kg mol(-1)) have shown maximum degree of swelling (287 wt%) but were found to be poor in loading and release behavior for centchroman. The microspheres with medium-molecular-weight (MMW) chitosan (1134 kg mol(-1)) have shown 250 wt% degree of swelling and 37.5 wt% loading of centchroman, but microspheres with high-molecular-weight (HMW) chitosan (2224 kg mol(-1)) have shown a low degree of swelling (150 wt%) and centchroman loading (30 wt%). The microspheres with MMW chitosan have released 82 wt% of loaded centchroman in a controlled release manner within a period of 70 h in comparison to low- (260 kg mol(-1)) and high-MW (2224 kg mol(-1)) chitosan microspheres. The chitosan microspheres with 62 wt% degree of deacetylation (DDA) were more efficient in the controlled release of centchroman in comparison to chitosan microspheres with low (48 wt%) and high-DDA (75 wt%). The fractional release of centchroman (M(t)/M(infinity)) from chitosan microspheres was used to predict the mechanism of drug release and to determine the diffusion constant (D) of centchroman.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17610856     DOI: 10.1016/j.carres.2007.06.009

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  9 in total

1.  Characterization of Chitosan-Based Scaffolds Seeded with Sheep Nasal Chondrocytes for Cartilage Tissue Engineering.

Authors:  Anamarija Rogina; Maja Pušić; Lucija Štefan; Alan Ivković; Inga Urlić; Marica Ivanković; Hrvoje Ivanković
Journal:  Ann Biomed Eng       Date:  2021-01-06       Impact factor: 3.934

2.  Glutaraldehyde and oxidised dextran as crosslinker reagents for chitosan-based scaffolds for cartilage tissue engineering.

Authors:  B Hoffmann; D Seitz; A Mencke; A Kokott; G Ziegler
Journal:  J Mater Sci Mater Med       Date:  2009-03-04       Impact factor: 3.896

Review 3.  Degradability of chitosan micro/nanoparticles for pulmonary drug delivery.

Authors:  Nazrul Islam; Isra Dmour; Mutasem O Taha
Journal:  Heliyon       Date:  2019-05-15

Review 4.  Multi-target tyrosine kinase inhibitor nanoparticle delivery systems for cancer therapy.

Authors:  Wenjing Xu; Chunping Ye; Xin Qing; Shengli Liu; Xinyi Lv; Wenjun Wang; Xiaochen Dong; Yewei Zhang
Journal:  Mater Today Bio       Date:  2022-07-12

5.  Formulation, characterization and cellular toxicity assessment of a novel bee-venom microsphere in prostate cancer treatment.

Authors:  Samia E El-Didamony; Reham I Amer; Ghada H El-Osaily
Journal:  Sci Rep       Date:  2022-08-02       Impact factor: 4.996

6.  Design and Characterization of Spray-Dried Chitosan-Naltrexone Microspheres for Microneedle-Assisted Transdermal Delivery.

Authors:  Abayomi T Ogunjimi; Jennifer Fiegel; Nicole K Brogden
Journal:  Pharmaceutics       Date:  2020-05-29       Impact factor: 6.321

Review 7.  Marine derived polysaccharides for biomedical applications: chemical modification approaches.

Authors:  Giovanna Gomez d'Ayala; Mario Malinconico; Paola Laurienzo
Journal:  Molecules       Date:  2008-09-03       Impact factor: 4.411

8.  Microencapsulation of Fluticasone Propionate and Salmeterol Xinafoate in Modified Chitosan Microparticles for Release Optimization.

Authors:  Nina Maria Ainali; Eleftheria Xanthopoulou; Georgia Michailidou; Alexandra Zamboulis; Dimitrios N Bikiaris
Journal:  Molecules       Date:  2020-08-26       Impact factor: 4.411

9.  Pharmacokinetic variables of medium molecular weight cross linked chitosan nanoparticles to enhance the bioavailability of 5-fluorouracil and reduce the acute oral toxicity.

Authors:  Aisha Sethi; Mahmood Ahmad; Tayyaba Huma; Waqas Ahmad
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.